Physician profile
Afser Shariff
NPI 1114920378
$4,327.80
in general payments reported to CMS, 2019-2025
26 companies · $863 in 2025
The $863 reported for 2025 was more than what 76% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $260 · 2020: $212 · 2021: $605 · 2022: $896 · 2023: $939 · 2024: $553 · 2025: $863.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,303 · Education: $51.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,302.98 |
| Education | $51.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $726.41 | 2022-2025 | Ubrelvy, Qulipta |
| Genzyme Corporation | $681.47 | 2019-2025 | |
| Optinose US, INC. | $578.80 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $527.08 | 2021-2025 | Dupixent |
| Stryker Corporation | $347.79 | 2019-2025 | Scopis Ent, Audion Et Dilation System |
| Inspire Medical Systems, INC. | $224.39 | 2022-2024 | Inspire |
| Pfizer INC. | $185.05 | 2023-2025 | |
| Glaxosmithkline, LLC. | $177.87 | 2021-2025 | Nucala |
| Aerin Medical INC. | $135.28 | 2019-2025 | |
| Acclarent, INC | $98.78 | 2019-2021 | |
| Smith+Nephew, INC. | $91.28 | 2020-2022 | |
| Medtronic, INC. | $84.91 | 2023-2025 | Propel, Stealthstation S8 Platform |
| Amgen INC. | $65.79 | 2025 | Tezspire |
| Grifols USA, LLC | $57.85 | 2023 | Prolastin-C Liquid, Xembify |
| Integra Lifesciences Corporation | $52.36 | 2023-2025 | Instruments-Orthopedic, Microfrance, Integra Duo |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $49.09 | 2025 | Tezspire |
| Alk-Abello, INC | $38.33 | 2020-2022 | |
| Axogen | $35.41 | 2024 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap, Axoguard Nerve Protector |
| Phadia US INC. | $34.84 | 2023-2025 | Immunocap |
| Lilly USA, LLC | $34.83 | 2021-2022 | |
| Ethicon US, LLC | $19.62 | 2024 | Harmonic |
| Biohaven Pharmaceutical Holding Company LTD. | $19.12 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $18.25 | 2023 | Seglentis |
| Vertex Pharmaceuticals Incorporated | $15.99 | 2025 | |
| Hikma Pharmaceuticals USA | $14.44 | 2023 | Ryaltris |
| Hologic Sales and Service, LLC | $12.77 | 2023 | Coolseal Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Afser Shariff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.